Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study

BACKGROUND: Although current guidelines recommend β‐blocker after acute myocardial infarction (MI), the role of β‐blocker has not been well investigated in the modern reperfusion era. In particular, the benefit of vasodilating β‐blocker over conventional β‐blocker is still unexplored. METHODS AND RE...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Jaehoon, Han, Jung‐Kyu, Kim, Young Jo, Kim, Chong Jin, Ahn, Youngkeun, Chan Cho, Myeong, Chae, Shung Chull, Chae, In‐Ho, Chae, Jei Keon, Seong, In‐Whan, Yang, Han‐Mo, Park, Kyung‐Woo, Kang, Hyun‐Jae, Koo, Bon‐Kwon, Jeong, Myung Ho, Kim, Hyo‐Soo, Ahn, Tae Hoon, Cha, Kwang Soo, Gwon, Hyeon‐Cheol, Hwang, Jin‐Yong, Joo, Seung Jae, Kim, Doo‐il, Kim, Kwon‐Bae, Oh, Dong Joo, Oh, Seok Kyu, Seung, Ki‐Bae, Yoon, Jung‐Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721887/
https://www.ncbi.nlm.nih.gov/pubmed/29066446
http://dx.doi.org/10.1161/JAHA.117.007063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721887/
https://www.ncbi.nlm.nih.gov/pubmed/29066446
http://dx.doi.org/10.1161/JAHA.117.007063

Ejemplares similares